Literature DB >> 11679461

Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris Prospective Study.

E Eschwège1, M A Charles, D Simon, N Thibult, B Balkau.   

Abstract

OBJECTIVE: To describe the change in diabetic status over 30 months. RESEARCH DESIGN AND METHODS: Cohort study of 5,400 Caucasian men from the Paris Prospective Study, aged 44-55 years, who were not known as having diabetes at baseline. Oral glucose tolerance tests were performed at baseline and after 30 months.
RESULTS: At baseline, diabetes was diagnosed in 2.9% of the men by fasting plasma glucose (FPG) > or =7.0 mmol/l and in 0.9% by isolated postchallenge hyperglycemia (IPH) (FPG <7.0 mmol/l and 2-h plasma glucose concentration > or =11.1 mmol/l), i.e., one in four of all men with newly diagnosed diabetes. Thirty months later, 42% of the men with diabetes diagnosed by FPG reverted to nondiabetic status, compared with 72% of those with diabetes diagnosed by IPH (P < 0.0001). For the men with diabetes diagnosed by FPG at baseline, diabetes had been diagnosed by a physician at 30 months in 11.5%, in contrast to only 3.9% of those with diabetes diagnosed by IPH (P < 0.05). For the 51 men with diabetes diagnosed by IPH at baseline, those who reverted to nondiabetic status had a lower frequency of family history of diabetes (P < 0.1), a higher mean corpuscular volume (P < 0.08), and a significantly higher total cholesterol concentration (P < 0.006) at baseline; in contrast, for the 156 men with diabetes diagnosed by FPG at baseline, the men who reverted to nondiabetic status and those who remained diabetic had similar characteristics.
CONCLUSIONS: In this epidemiological study, diabetes diagnosed by one FPG concentration was more stable than diabetes diagnosed by one IPH; in clinical practice, the diagnosis of diabetes requires confirmation of the hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11679461     DOI: 10.2337/diacare.24.11.1941

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  19 in total

1.  Progression from newly acquired impaired fasting glusose to type 2 diabetes.

Authors:  Gregory A Nichols; Teresa A Hillier; Jonathan B Brown
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

Review 2.  The oral glucose tolerance test for the diagnosis of diabetes mellitus in patients during acute coronary syndrome hospitalization: a meta-analysis of diagnostic test accuracy.

Authors:  Yicong Ye; Hongzhi Xie; Xiliang Zhao; Shuyang Zhang
Journal:  Cardiovasc Diabetol       Date:  2012-12-27       Impact factor: 9.951

3.  Efficacy of primary prevention interventions when fasting and postglucose dysglycemia coexist: analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2).

Authors:  Ambady Ramachandran; Nanditha Arun; Ananth Samith Shetty; Chamukuttan Snehalatha
Journal:  Diabetes Care       Date:  2010-06-02       Impact factor: 19.112

Review 4.  Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.

Authors:  Brian Buijsse; Rebecca K Simmons; Simon J Griffin; Matthias B Schulze
Journal:  Epidemiol Rev       Date:  2011-05-27       Impact factor: 6.222

5.  Two-step approach for the prediction of future type 2 diabetes risk.

Authors:  Muhammad A Abdul-Ghani; Tamam Abdul-Ghani; Michael P Stern; Jasmina Karavic; Tiinamaija Tuomi; Insoma Bo; Ralph A Defronzo; Leif Groop
Journal:  Diabetes Care       Date:  2011-07-25       Impact factor: 19.112

6.  Risk for incident diabetes is greater in prediabetic men with HIV than without HIV.

Authors:  Laurence Slama; Benjamin W Barrett; Alison G Abraham; Frank J Palella; Lawrence Kingsley; Jean Paul Viard; Jordan E Lake; Todd T Brown
Journal:  AIDS       Date:  2021-08-01       Impact factor: 4.632

7.  Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study.

Authors:  Paul G H Janssen; Kees J Gorter; Ronald P Stolk; Mehmet Akarsubasi; Guy E H M Rutten
Journal:  BMC Fam Pract       Date:  2008-12-16       Impact factor: 2.497

8.  Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China.

Authors:  Xianghai Zhou; Zengchang Pang; Weiguo Gao; Shaojie Wang; Lei Zhang; Feng Ning; Qing Qiao
Journal:  Diabetes Care       Date:  2009-12-10       Impact factor: 19.112

Review 9.  Plasma glucose concentration and prediction of future risk of type 2 diabetes.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

10.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.